NYSE:NSPR

Inspiremd Stock Insider Trading

Healthcare > Medical - Devices

Buy NSPR

*Your capital is at risk

$0.96

-0.0499 (-4.94%)

At Close: Jun 03, 2026

InspireMD Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 71.38. In total, the insiders bought 4.93M and sold 566.48K NSPR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	71.38
● Buy	4.93M shares
● Sell	566.48K shares
68% Buy Activity Moderate Negative Correlation
Sell Signal Low Confidence May 19, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 71.38. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 14, 2026 Buy	Common Stock A-Award	Dearen Danny L. Director	Director	44 030 Value: $70.0K
Jan 14, 2026 Buy	Common Stock A-Award	Roubin Gary S Director	Director	88 053 Value: $140.0K
Jan 14, 2026 Buy	Restricted Stock Units A-Award	Slosman Marvin CEO And President	CEO / President	1 114 792 Value: $1.77M
Jan 14, 2026 Buy	Common Stock A-Award	Ward Scott R. Director	Director	88 053 Value: $140.0K
Jan 14, 2026 Buy	Common Stock A-Award	Tommasoli Andrea Chief Operating Officer	C-Suite Officer	226 695 Value: $360.4K
Jan 14, 2026 Buy	Common Stock A-Award	Stuka Paul Director	Director	132 076 Value: $210.0K
Jan 14, 2026 Buy	Common Stock A-Award	Lawless Michael A Chief Financial Officer	C-Suite Officer	226 695 Value: $360.4K
Jan 14, 2026 Buy	Common Stock A-Award	Gleason Shane Thomas Chief Commercial Officer	Officer	453 390 Value: $720.9K
Dec 30, 2025 Buy	Options to purchase common stock (right to buy) A-Award	Arnold Kathryn Director	Director	26 276 Value: $49.7K
Dec 30, 2025 Buy	Common Stock A-Award	Arnold Kathryn Director	Director	55 556 Value: $105.0K
Dec 09, 2025 Buy	Common Stock P-Purchase	Stuka Paul Director	Director	5 073 Value: $9K
Dec 05, 2025 Buy	Common Stock P-Purchase	Stuka Paul Director	Director	5 073 Value: $9K
Dec 04, 2025 Buy	Common Stock P-Purchase	Stuka Paul Director	Director	10 130 Value: $18.7K
Nov 12, 2025 Buy	Common Stock P-Purchase	Stuka Paul Director	Director	13 431 Value: $21.8K
Oct 07, 2025 Buy	Common Stock A-Award	Roubin Gary S Director	Director	48 000 Value: $116.2K
Oct 07, 2025 Buy	Common Stock A-Award	Roubin Gary S Director	Director	48 000 Value: $116.2K
Sep 16, 2025 Buy	Common Stock	Dearen Danny L. Director	Director	0 Value: $0
Sep 16, 2025 Buy	Options to purchase common stock (right to buy)	Dearen Danny L. Director	Director	28 206 Value: $68.0K
Sep 16, 2025 Buy	Options to purchase common stock (right to buy)	Dearen Danny L. Director	Director	28 206 Value: $68.0K
Sep 16, 2025 Buy	Common Stock	Dearen Danny L. Director	Director	0 Value: $0
Sep 15, 2025 Buy	Common Stock A-Award	Kester Thomas J Director	Director	37 815 Value: $90.0K
Sep 15, 2025 Buy	Options to purchase common stock (right to buy) A-Award	Kester Thomas J Director	Director	19 041 Value: $45.3K
Sep 15, 2025 Buy	Options to purchase common stock (right to buy) A-Award	Kester Thomas J Director	Director	19 041 Value: $45.3K
Sep 15, 2025 Buy	Common Stock A-Award	Kester Thomas J Director	Director	37 815 Value: $90.0K
Jul 31, 2025 Buy	Common Stock	Cohen Raymond W Director	Director	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT INSPIREMD INC

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, ...

Read Full Profile Here